Takehiko Tode

794 total citations
22 papers, 666 citations indexed

About

Takehiko Tode is a scholar working on Molecular Biology, Reproductive Medicine and Oncology. According to data from OpenAlex, Takehiko Tode has authored 22 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Reproductive Medicine and 4 papers in Oncology. Recurrent topics in Takehiko Tode's work include Ginseng Biological Effects and Applications (7 papers), Ovarian cancer diagnosis and treatment (6 papers) and Endometriosis Research and Treatment (4 papers). Takehiko Tode is often cited by papers focused on Ginseng Biological Effects and Applications (7 papers), Ovarian cancer diagnosis and treatment (6 papers) and Endometriosis Research and Treatment (4 papers). Takehiko Tode collaborates with scholars based in Japan. Takehiko Tode's co-authors include Ichiro Nagata, Junko Hirata, Yoshihiro Kikuchi, Tsunekazu Kita, J Hirata, Kazuya Kudoh, Kenji Ishii, Nariyoshi Shinomiya, Hidenori Sasa and Yoshiaki Kikuchi and has published in prestigious journals such as International Journal of Cancer, European Journal of Cancer and Gynecologic Oncology.

In The Last Decade

Takehiko Tode

22 papers receiving 620 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takehiko Tode Japan 13 453 177 130 114 70 22 666
Ming‐Tsung Lai Taiwan 14 243 0.5× 85 0.5× 55 0.4× 55 0.5× 50 0.7× 23 519
Shinobu Sakamoto Japan 13 109 0.2× 37 0.2× 63 0.5× 74 0.6× 47 0.7× 37 388
Jeong‐Hwa Woo South Korea 13 154 0.3× 30 0.2× 96 0.7× 40 0.4× 118 1.7× 23 464
Mi Hwa Han South Korea 13 195 0.4× 111 0.6× 34 0.3× 26 0.2× 121 1.7× 20 541
Po‐Han Lin Taiwan 13 156 0.3× 49 0.3× 112 0.9× 33 0.3× 57 0.8× 20 444
Xinying Zhu China 12 403 0.9× 40 0.2× 25 0.2× 64 0.6× 107 1.5× 16 664
Abnish K. Gautam India 10 368 0.8× 23 0.1× 16 0.1× 64 0.6× 36 0.5× 15 495
Naoshad Muhammad United States 15 459 1.0× 52 0.3× 10 0.1× 134 1.2× 84 1.2× 26 799
Hua Nian China 12 327 0.7× 137 0.8× 10 0.1× 69 0.6× 51 0.7× 15 537
Shanmuga Reddy Chilakapati United States 7 111 0.2× 21 0.1× 75 0.6× 138 1.2× 86 1.2× 12 380

Countries citing papers authored by Takehiko Tode

Since Specialization
Citations

This map shows the geographic impact of Takehiko Tode's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takehiko Tode with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takehiko Tode more than expected).

Fields of papers citing papers by Takehiko Tode

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takehiko Tode. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takehiko Tode. The network helps show where Takehiko Tode may publish in the future.

Co-authorship network of co-authors of Takehiko Tode

This figure shows the co-authorship network connecting the top 25 collaborators of Takehiko Tode. A scholar is included among the top collaborators of Takehiko Tode based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takehiko Tode. Takehiko Tode is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fujii, Kazuyuki, Naoki Sasaki, Masashi Takano, et al.. (2004). [The efficacy of Shakuyaku-Kanzo-to for peripheral nerve dysfunction in paclitaxel combination chemotherapy for epithelial ovarian carcinoma].. PubMed. 31(10). 1537–40. 18 indexed citations
2.
3.
Kudoh, Kazuya, Takehiko Tode, Junko Hirata, et al.. (1999). Preoperative Determination of Several Serum Tumor Markers in Patients with Primary Epithelial Ovarian Carcinoma. Gynecologic and Obstetric Investigation. 47(1). 52–57. 48 indexed citations
4.
Tode, Takehiko, et al.. (1999). Effect of Korean red ginseng on psychological functions in patients with severe climacteric syndromes. International Journal of Gynecology & Obstetrics. 67(3). 169–174. 67 indexed citations
5.
Kikuchi, Yoshiaki, Kenji Yamamoto, Toshiyuki Kita, et al.. (1999). Bcl-2 as a predictor of chemosensitivity and prognosis in primary epithelial ovarian cancer. European Journal of Cancer. 35(8). 1214–1219. 77 indexed citations
6.
Kikuchi, Yoshihiro, Takehiko Tode, Junko Hirata, et al.. (1998). Inhibitory Effects of Ginsenoside Rh2 on Tumor Growth in Nude Mice Bearing Human Ovarian Cancer Cells. Japanese Journal of Cancer Research. 89(7). 733–740. 163 indexed citations
7.
8.
Kikuchi, Yoshiaki, et al.. (1997). Effects of granulocyte-colony-stimulating factor and interleukin-2 on ascites formation and the survival time of nude mice bearing human ovarian cancer cells. Cancer Immunology Immunotherapy. 43(5). 257–261. 2 indexed citations
9.
Hirata, Junko, Kenji Yamamoto, Kenji Ishii, et al.. (1997). Altered Expression of γ‐Glutamylcysteine Synthetase, Metallothionein and Topoisomerase I or II during Acquisition of Drug Resistance to Cisplatin in Human Ovarian Cancer Cells. Japanese Journal of Cancer Research. 88(2). 213–217. 14 indexed citations
10.
Ishii, Kenji, Kenji Yamamoto, Toshiyuki Kita, et al.. (1997). Prognosis of patients with primary epithelial ovarian carcinoma who were not successfully cytoreduced. Oncology Reports. 4(1). 107–10. 1 indexed citations
11.
Hirata, Junko, et al.. (1995). Complete Inhibition of Human Ovarian Cancer Xenografts in Nude Mice by Suramin and cis-Diamminedichloroplatinum(II). Gynecologic Oncology. 58(1). 11–15. 6 indexed citations
12.
Kikuchi, Yosuke, et al.. (1995). A ROLE OF GLUTATHIONE IN RESISTANCE MECHANISMS TO CIS-DIAMMINEDICHLOROPLATINUM(II) IN HUMAN OVARIAN-CANCER CELL-LINES IN-VITRO. Oncology Reports. 2(5). 763–8. 2 indexed citations
13.
Ishii, Kenji, T Kita, J Hirata, et al.. (1995). [Circumvention of cisplatin resistant ovarian cancer cells by antiestrogens].. PubMed. 47(1). 19–26. 1 indexed citations
14.
Hirata, Junko, et al.. (1994). Endometriotic Tissues Produce Immunosuppressive Factors. Gynecologic and Obstetric Investigation. 37(1). 43–47. 24 indexed citations
15.
Kikuchi, Yoshihiro, et al.. (1993). Enhancement of Antiproliferative Effect of cis-Diamminedichloroplatinum (II) by Clomiphene and Tamoxifen in Human Ovarian Cancer Cells. Gynecologic Oncology. 49(3). 365–372. 19 indexed citations
16.
Hirata, Junko, Yoshihiro Kikuchi, Tsunekazu Kita, et al.. (1993). Modulation of sensitivity of human ovarian cancer cells to cis‐diamminedichloroplatinum(II) by 12‐O‐tetradecanoylphorbol‐13‐acetate and D, L‐buthionine‐S, R‐sulphoximine. International Journal of Cancer. 55(3). 521–527. 15 indexed citations
17.
Tode, Takehiko, et al.. (1993). Inhibitory effects by oral administration of ginsenoside Rh2 on the growth of human ovarian cancer cells in nude mice. Journal of Cancer Research and Clinical Oncology. 120(1-2). 24–26. 68 indexed citations
18.
Hirata, Junichi, et al.. (1993). [Interleukin-6 production in endometriosis].. PubMed. 45(5). 415–22. 1 indexed citations
19.
Tode, Takehiko, Masanori Kikuchi, Hidenori Sasa, et al.. (1992). [In vitro and in vivo effects of ginsenoside Rh2 on the proliferation of serous cystadenocarcinoma of the human ovary].. PubMed. 44(5). 589–94. 4 indexed citations
20.
Kikuchi, Yoshihiro, et al.. (1991). Inhibition of human ovarian cancer cell proliferation in vitro by ginsenoside Rh2 and adjuvant effects to cisplatin in vivo. Anti-Cancer Drugs. 2(1). 63–68. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ming‐Tsung Lai Breakdown of academic impact, for papers by Shinobu Sakamoto Breakdown of academic impact, for papers by Jeong‐Hwa Woo Breakdown of academic impact, for papers by Mi Hwa Han Breakdown of academic impact, for papers by Po‐Han Lin Breakdown of academic impact, for papers by Xinying Zhu Breakdown of academic impact, for papers by Abnish K. Gautam Breakdown of academic impact, for papers by Naoshad Muhammad Breakdown of academic impact, for papers by Hua Nian Breakdown of academic impact, for papers by Shanmuga Reddy Chilakapati
Rankless by CCL
2026